Mahamaya Lifescience Stock Price Analysis and Quick Research Report. Is Mahamaya Lifescience an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Mahamaya Lifescience. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Mahamaya Lifescience has a PE ratio of 20.9942128995746 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Mahamaya Lifescience has ROA of 8.5131% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Mahamaya Lifescience has a Current ratio of 1.1939.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Mahamaya Lifescience has a ROE of 34.1666%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Mahamaya Lifescience has a Debt to Equity ratio of 1.1638 which means that the company has low proportion of debt in its capital.

• Sales growth: Mahamaya Lifescience has reported revenue growth of 63.4877% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Mahamaya Lifescience for the current financial year is 8.76574776470516%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Mahamaya Lifescience is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Mahamaya Lifescience is Rs 5.4777. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Mahamaya Lifescience in Ticker for free. Also, one can get the intrinsic value of Mahamaya Lifescience by using Valuation Calculators, which are available with a Finology ONE subscription. 

Mahamaya Lifescience FAQs

Q1. What is Mahamaya Lifescience share price today?
Ans: The current share price of Mahamaya Lifescience is Rs 115.

Q2. What is the market capitalisation of Mahamaya Lifescience?
Ans: Mahamaya Lifescience has a market capitalisation of Rs 269.1575 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Mahamaya Lifescience?
Ans: The PE ratio of Mahamaya Lifescience is 20.9942128995746 and the P/B ratio of Mahamaya Lifescience is 2.35794411877477, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Mahamaya Lifescience share?
Ans: The 52-week high share price of Mahamaya Lifescience is Rs 122.15, and the 52-week low share price of Mahamaya Lifescience is Rs 111.

Q5. Does Mahamaya Lifescience pay dividends?
Ans: Currently, Mahamaya Lifescience does not pay dividends. Dividend yield of Mahamaya Lifescience is around 0%.

Q6. What are the face value and book value of Mahamaya Lifescience shares?
Ans: The face value of Mahamaya Lifescience shares is Rs 10, while the book value per share of Mahamaya Lifescience is around Rs 48.7713. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Mahamaya Lifescience?
Ans: Mahamaya Lifescience has a total debt of Rs 58.035 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Mahamaya Lifescience?
Ans: The ROE of Mahamaya Lifescience is 34.1666% and ROCE of Mahamaya Lifescience is 26.0045%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Mahamaya Lifescience a good buy for the long term?
Ans: The Mahamaya Lifescience long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Mahamaya Lifescience undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Mahamaya Lifescience appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Mahamaya Lifescience’s financials?
Ans: You can review Mahamaya Lifescience’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.